Thursday, March 23, 2017 3:59:21 PM
This is what she could tell me. The next conference call is tentatively scheduled for the third week in April. The addition of Anthony C has been a big plus and he is working around the clock...on what she would not tell me. I think we all have a short list of what that should be. Nader and Anthony C understand and want what everyone here on this board understands and wants and a whole lot more. The FDA is a complex animal and they are not in control - the FDA is, and Anthony C's job is utilize his experience and play the game precisely.
I could speculate but that is not really of value because it is speculation based on limited information. But I can't help myself so take it for what it's worth.
- I'm not sitting on pins and needles waiting for a PR that is going to push the SP to the moon tomorrow. I think we still have a ways to go.
- Anthoy C is getting down to business and is laser focused on seeing Pro-140 through to FDA Approval and an eventual buyout. He is the new Sheriff in town.
- Cytodyn knows what they have in Pro-140 and are not worried about the data. They do understand the importance of screening and enrolling the right patients vs. speed of enrollment which could potentially sink Pro-140.
-The tipping point for BP will be interim data on the P3 Mono Trial.
- If you believe in the science quit speculating as to the inefficiencies of management. This isn't Anthony C's first rodeo. If you think you know more and have a better way you are wrong because your nothing more than a Monday morning Quarterback.
As many wise posters have repeatedly posted - R-E-L-A-X. This is going to reward clear thinkers and the company will be sold at value that will dwarf any future diluting that is deemed necessary.
Time to hit the golf course and enjoy life. The future is bright and Life is good!
Recent CYDY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM